LEUKEMIA CUTIS

Clinical trials for LEUKEMIA CUTIS explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA CUTIS trials appear

Sign up with your email to follow new studies for LEUKEMIA CUTIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug cocktail shows promise in Tough-to-Treat leukemia

Disease control Ongoing

This large Phase 3 trial tests whether adding two targeted drugs (bortezomib and sorafenib) to standard chemotherapy helps people with newly diagnosed acute myeloid leukemia (AML) live longer without the cancer returning. The study includes over 1,600 participants and focuses on …

Matched conditions: LEUKEMIA CUTIS

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 07, 2026 18:41 UTC

LEUKEMIA CUTIS

Get alerted when new LEUKEMIA CUTIS trials appear

New drug cocktail shows promise in Tough-to-Treat leukemia